Erratum: NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression (Journal of Clinical Investigation (2023) 133:3 (1-19) DOI: 10.1172/JCI157272)

Yen Po Tsao; Fang Yu Tseng; Chih Wei Chao; Ming Han Chen; Yi Chen Yeh; Babamale Olarewaju Abdulkareem; Se Yi Chen; Wen Ting Chuang; Pei Ching Chang; I. Chun Chen; Pin Hsuan Wang; Chien Sheng Wu; Chang Youh Tsai; Szu Ting Chen

doi:10.1172/JCI171350

Erratum: NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression (Journal of Clinical Investigation (2023) 133:3 (1-19) DOI: 10.1172/JCI157272)

Yen Po Tsao, Fang Yu Tseng, Chih Wei Chao, Ming Han Chen, Yi Chen Yeh, Babamale Olarewaju Abdulkareem, Se Yi Chen, Wen Ting Chuang, Pei Ching Chang, I. Chun Chen, Pin Hsuan Wang, Chien Sheng Wu, Chang Youh Tsai, Szu Ting Chen

研究成果: Comment/debate

1 引文斯高帕斯（Scopus）

摘要

Figures 1, F, J, and Q, reported incorrect P values. For Figure 5, C and E, the x axis labels were incorrect and h.p.s. was not defined. Figure 5F was missing P values. In addition, Dr. Szu-Ting Chen’s affiliations were incorrect. The correct figure parts, definition, and affiliations list are below. (Figure Presented).

原文	English
文章編號	e171350
期刊	Journal of Clinical Investigation
卷	133
發行號	9
DOIs	https://doi.org/10.1172/JCI171350
出版狀態	Published - 1 5月 2023

存取文件

10.1172/JCI171350

其它文件與鏈接

Link to publication in Scopus

引用此

Tsao, Y. P., Tseng, F. Y., Chao, C. W., Chen, M. H., Yeh, Y. C., Abdulkareem, B. O., Chen, S. Y., Chuang, W. T., Chang, P. C., Chen, I. C., Wang, P. H., Wu, C. S., Tsai, C. Y., & Chen, S. T. (2023). Erratum: NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression (Journal of Clinical Investigation (2023) 133:3 (1-19) DOI: 10.1172/JCI157272). Journal of Clinical Investigation, 133(9), 文章 e171350. https://doi.org/10.1172/JCI171350

@article{1128bff790684589b02692949dcf7a29,

title = "Erratum: NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression (Journal of Clinical Investigation (2023) 133:3 (1-19) DOI: 10.1172/JCI157272)",

abstract = "Figures 1, F, J, and Q, reported incorrect P values. For Figure 5, C and E, the x axis labels were incorrect and h.p.s. was not defined. Figure 5F was missing P values. In addition, Dr. Szu-Ting Chen{\textquoteright}s affiliations were incorrect. The correct figure parts, definition, and affiliations list are below. (Figure Presented).",

author = "Tsao, {Yen Po} and Tseng, {Fang Yu} and Chao, {Chih Wei} and Chen, {Ming Han} and Yeh, {Yi Chen} and Abdulkareem, {Babamale Olarewaju} and Chen, {Se Yi} and Chuang, {Wen Ting} and Chang, {Pei Ching} and Chen, {I. Chun} and Wang, {Pin Hsuan} and Wu, {Chien Sheng} and Tsai, {Chang Youh} and Chen, {Szu Ting}",

year = "2023",

month = may,

day = "1",

doi = "10.1172/JCI171350",

language = "English",

volume = "133",

journal = "Journal of Clinical Investigation",

issn = "0021-9738",

publisher = "American Society for Clinical Investigation",

number = "9",

}

Tsao, YP, Tseng, FY, Chao, CW, Chen, MH, Yeh, YC, Abdulkareem, BO, Chen, SY, Chuang, WT, Chang, PC, Chen, IC, Wang, PH, Wu, CS, Tsai, CY & Chen, ST 2023, 'Erratum: NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression (Journal of Clinical Investigation (2023) 133:3 (1-19) DOI: 10.1172/JCI157272)', Journal of Clinical Investigation, 卷 133, 編號 9, e171350. https://doi.org/10.1172/JCI171350

TY - JOUR

T1 - Erratum

T2 - NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression (Journal of Clinical Investigation (2023) 133:3 (1-19) DOI: 10.1172/JCI157272)

AU - Tsao, Yen Po

AU - Tseng, Fang Yu

AU - Chao, Chih Wei

AU - Chen, Ming Han

AU - Yeh, Yi Chen

AU - Abdulkareem, Babamale Olarewaju

AU - Chen, Se Yi

AU - Chuang, Wen Ting

AU - Chang, Pei Ching

AU - Chen, I. Chun

AU - Wang, Pin Hsuan

AU - Wu, Chien Sheng

AU - Tsai, Chang Youh

AU - Chen, Szu Ting

PY - 2023/5/1

Y1 - 2023/5/1

N2 - Figures 1, F, J, and Q, reported incorrect P values. For Figure 5, C and E, the x axis labels were incorrect and h.p.s. was not defined. Figure 5F was missing P values. In addition, Dr. Szu-Ting Chen’s affiliations were incorrect. The correct figure parts, definition, and affiliations list are below. (Figure Presented).

AB - Figures 1, F, J, and Q, reported incorrect P values. For Figure 5, C and E, the x axis labels were incorrect and h.p.s. was not defined. Figure 5F was missing P values. In addition, Dr. Szu-Ting Chen’s affiliations were incorrect. The correct figure parts, definition, and affiliations list are below. (Figure Presented).

UR - http://www.scopus.com/inward/record.url?scp=85159243311&partnerID=8YFLogxK

U2 - 10.1172/JCI171350

DO - 10.1172/JCI171350

M3 - Comment/debate

C2 - 37115700

AN - SCOPUS:85159243311

SN - 0021-9738

VL - 133

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

IS - 9

M1 - e171350

ER -

Erratum: NLRP12 is an innate immune checkpoint for repressing IFN signatures and attenuating lupus nephritis progression (Journal of Clinical Investigation (2023) 133:3 (1-19) DOI: 10.1172/JCI157272)

摘要

存取文件

其它文件與鏈接

指紋

引用此